Orthomyxoviridae

From WikiMD's WELLNESSPEDIA

Orthomyxoviridae is a family of RNA viruses that includes five genera: Influenzavirus A, Influenzavirus B, Influenzavirus C, Isavirus, and Thogotovirus. The viruses in this family are characterized by an enveloped virion that measures approximately 100 nanometers in diameter and a segmented genome.

Structure and Genome[edit]

The viruses in the Orthomyxoviridae family are enveloped, with a spherical or filamentous shape. The envelope of the virus is derived from the host cell membrane, and contains two major glycoproteins, hemagglutinin (H) and neuraminidase (N). These proteins play a crucial role in the virus's ability to infect host cells.

The genome of Orthomyxoviridae viruses is made up of segmented, negative-sense, single-stranded RNA. This segmented nature of the genome allows for the exchange of gene segments, a process known as genetic reassortment. This is a major factor in the emergence of new strains of influenza viruses.

Replication[edit]

Orthomyxoviridae viruses replicate in the nucleus of the host cell, a unique feature among RNA viruses. The replication process involves the transcription of the viral RNA into complementary RNA (cRNA), which is then used as a template for the production of viral RNA.

Pathogenesis and Immunity[edit]

Viruses in the Orthomyxoviridae family are responsible for a wide range of diseases in humans and animals. The most well-known of these is influenza, caused by Influenzavirus A and B. Influenza is a highly contagious respiratory illness that can cause severe illness and death, particularly in high-risk populations.

Immunity to Orthomyxoviridae viruses is primarily mediated by the immune system's response to the H and N glycoproteins on the surface of the virus. However, the high rate of mutation in these proteins, a process known as antigenic drift, allows the virus to evade the immune response, leading to recurrent epidemics.

See Also[edit]

References[edit]

Orthomyxoviridae[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.